UK 19:46 Monday, 26 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
FastForward Innovations (FFWD) has announced results for its year ended 31st March 2020 including “a large portion of our investments have continued to make positive advances and reach significant milestones in their development”, though also “some challenges”... and this share tip from us is almost 100% ahead on an offer to bid basis after just two months!
Tom covered much of the nonsense surrounding the FastForward Innovations’ (FFWD) placing last week (HERE) but I wanted to look at how Jim Mellon and Lorne Abony got themselves into that particular mess as they seem to have taken a couple of plays straight out of “star fund manager” Neil Woodford’s book.
The results which came out in early July made it clear to anyone who could do basic maths that Jim Mellon's FastForward (FFWD) would be passing the hat around shortly. Three ramptastic RNS's followed and today I can reveal that the company is on the road trying to raise £5 million in fresh equity.
If anyone thought anything else other that FastForward Innovations was merely the personal investment vehicle for Jim Mellon and Lorne Abony to dip into at will, today’s massive related party deal with Mellon’s Juvenescence Limited puts it beyond any doubt.
Madness is afoot at FastForward Innovations (FFWD) with the excitement about the impending listing of its cannabis play, Nuuvera, driving the share price up as high as 30p yesterday. This makes no rational sense as I will endeavour to explain but the summary is simple – if you like Nuuvera, buy it in the market for its market value rather than at 4-5 times its value!
The one thing I hate more than being wrong about a share recommendation is being spoofed and falling for it, which is what I think has happened with FastForward Innovations (FFWD). Can’t believe I fell for it but I’m done now – SELL.
I’ve been hugely critical of FastForward Innovations (FFWD) in the past, in the main due to the lack of transparency and the poor performance of Schoold and Vemo, Lorne Abony’s own investments in FastForward’s portfolio; however, today’s news is much more promising and I actually wonder whether it’s worth a dabble!
Tom covered the news of the failed Schoold / Lingo Media merger that FastForward Innovations (FFWD) announced on Friday in his Bearcast (HERE); however, I thought it was worth taking a closer look at the numbers and pondering when the next major write down to FastForward’s portfolio, and Lorne Abony’s reputation, will come.
Investors in various Jim Mellon connected companies such as FastForward Innovations (FFWD) and Port Erin Biopharma (PEBI) may be interested in this analysis of Diabetic Boot Company’s latest six-month accounts to 31 December 2016. The bad news is that it is still losing a fortune although the good news is that at least Mr Mellon is now largely funding it himself.
I’ve been pretty critical of Jim Mellon's FastForward Innovations (FFWD) and its CEO, Lorne Abony, in the past but today’s news is a positive step for one of its investee companies, Nuuvera, and worthy of comment and the only negative relates to the obvious blunder that offends my OCD proof-reading nature.
After months of promises and delays, Jim Mellon's FastForward Innovations (FFWD) finally provided further details of the potential merger of investee company Schoold with Lingo Media this morning. I can see why it was reticent about making the announcement as it doesn’t make pretty reading.
Tom covered the key headlines on the year-end results of Jim Mellon's FastForward Innovations (FFWD) on Friday but I wanted to focus in on a couple of points, most notably the exorbitant amount Lorne Abony, CEO, gets paid considering the despicable way in which he treats his shareholders and the shocking performance, and non-disclosure, of one of the investments that he brought to the table, namely Vemo.
FastForward (FFWD) the investment company chaired by my old friend, the offshore based asset stripper Mr Jim Mellon, served up results for the year to 31 March today. Cynical Bear will give them the full workover they merit over the weekend but I could not give my old pal Jim a completely free pass. The numbers are shite
To end my trilogy of tenuously connected pieces, I’m taking a look at four ongoing coma-inducing delays at each of FastForward Innovations (FFWD), i3 Energy and, of course, Aidan Earley’s Newco and wonder which, if any, will win this slow and laborious race.
I’ve written a few times on the travails of The Diabetic Boot Company over time, usually after yet another Jim Mellon-related company lends or invests money in this biotech pipedream. Well, its results have finally come out, two months late, and they make interesting reading.
